PHILADELPHIA: The regenerative medicine market is tipped to impact the medical industry massively in the coming years, and companies are coming up with revolutionary ways of influencing the market.
Big Pharmaceutical companies in particular are beginning to show increased interest by making various acquisitions, and are also engaged in partnership programs with startup research companies.
Regenerative medicines could potentially provide lasting solutions to some of the world’s leading chronic diseases, and with Americans spending up to $300 billion annually on healthcare, the opportunity is huge.
A recent report forecasts that the regenerative medicine market will reach $67 billion in the next five years…